Class information for:
Level 1: ORAL BIOL ORAL MED//CD3 ZETA//ZETA CHAIN

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
25218 287 48.7 90%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
10 3       IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL 134299
140 2             IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY 23462
25218 1                   ORAL BIOL ORAL MED//CD3 ZETA//ZETA CHAIN 287

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ORAL BIOL ORAL MED address 585159 4% 50% 11
2 CD3 ZETA authKW 567417 6% 33% 16
3 ZETA CHAIN authKW 357589 4% 31% 11
4 ZETA CHAIN EXPRESSION authKW 319184 1% 100% 3
5 JANE JERRY WEINTRAUB RECONSTRUCT BIOTECHNOL address 246196 6% 13% 18
6 TCR ZETA authKW 239380 2% 38% 6
7 OSCSCS authKW 212789 1% 100% 2
8 REGULATORY NK authKW 212789 1% 100% 2
9 SERV CLIN 3 address 191508 1% 60% 3
10 CD3 ZETA CHAIN authKW 177318 2% 33% 5

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 2515 48% 0% 139
2 Immunology 2013 40% 0% 116
3 Hematology 94 6% 0% 18
4 Cell Biology 87 11% 0% 31
5 Medicine, Research & Experimental 80 7% 0% 21
6 Gastroenterology & Hepatology 5 2% 0% 6
7 Obstetrics & Gynecology 2 2% 0% 5
8 Pathology 1 1% 0% 4
9 Dermatology 1 1% 0% 3
10 Otorhinolaryngology 0 1% 0% 2

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ORAL BIOL ORAL MED 585159 4% 50% 11
2 JANE JERRY WEINTRAUB RECONSTRUCT BIOTECHNOL 246196 6% 13% 18
3 SERV CLIN 3 191508 1% 60% 3
4 BIOL CELULAR MOL FABIO 141858 1% 67% 2
5 IMMUNE GENETHER Y 141858 1% 67% 2
6 AMSTERDAM GYNAECOL ONCOL GRP 106395 0% 100% 1
7 CARDINAL BERBARDIN CANC 106395 0% 100% 1
8 CHAO FAMILY COMPREHENES CANC 106395 0% 100% 1
9 DEOT MED ONCOL A 106395 0% 100% 1
10 DISPLASIAS 106395 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CANCER IMMUNOLOGY IMMUNOTHERAPY 14109 8% 1% 24
2 CLINICAL CANCER RESEARCH 4471 9% 0% 25
3 CRITICAL REVIEWS IN ONCOGENESIS 3245 1% 2% 2
4 CYTOKINES AND MOLECULAR THERAPY 1968 0% 2% 1
5 JOURNAL OF IMMUNOTHERAPY 1573 2% 0% 5
6 JOURNAL OF CANCER 1274 1% 0% 3
7 CLINICAL IMMUNOLOGY 988 2% 0% 5
8 NATURAL IMMUNITY 763 0% 1% 1
9 INTERNATIONAL JOURNAL OF CANCER 744 4% 0% 12
10 JOURNAL OF IMMUNOLOGY 622 6% 0% 18

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 CD3 ZETA 567417 6% 33% 16 Search CD3+ZETA Search CD3+ZETA
2 ZETA CHAIN 357589 4% 31% 11 Search ZETA+CHAIN Search ZETA+CHAIN
3 ZETA CHAIN EXPRESSION 319184 1% 100% 3 Search ZETA+CHAIN+EXPRESSION Search ZETA+CHAIN+EXPRESSION
4 TCR ZETA 239380 2% 38% 6 Search TCR+ZETA Search TCR+ZETA
5 OSCSCS 212789 1% 100% 2 Search OSCSCS Search OSCSCS
6 REGULATORY NK 212789 1% 100% 2 Search REGULATORY+NK Search REGULATORY+NK
7 CD3 ZETA CHAIN 177318 2% 33% 5 Search CD3+ZETA+CHAIN Search CD3+ZETA+CHAIN
8 MAC 1 CELL 141858 1% 67% 2 Search MAC+1+CELL Search MAC+1+CELL
9 ABNORMAL ASSEMBLY 106395 0% 100% 1 Search ABNORMAL+ASSEMBLY Search ABNORMAL+ASSEMBLY
10 ACTIVATION OF CYTOKINE SECRETION 106395 0% 100% 1 Search ACTIVATION+OF+CYTOKINE+SECRETION Search ACTIVATION+OF+CYTOKINE+SECRETION

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 CISZAK, L , KOSMACZEWSKA, A , WERYNSKA, B , SZTEBLICH, A , JANKOWSKA, R , FRYDECKA, I , (2009) IMPAIRED ZETA CHAIN EXPRESSION AND IFN-GAMMA PRODUCTION IN PERIPHERAL BLOOD T AND NK CELLS OF PATIENTS WITH ADVANCED LUNG CANCER.ONCOLOGY REPORTS. VOL. 21. ISSUE 1. P. 173-184 27 63% 13
2 KUSS, I , SAITO, T , JOHNSON, JT , WHITESIDE, TL , (1999) CLINICAL SIGNIFICANCE OF DECREASED ZETA CHAIN EXPRESSION IN PERIPHERAL BLOOD LYMPHOCYTES OF PATIENTS WITH HEAD AND NECK CANCER.CLINICAL CANCER RESEARCH. VOL. 5. ISSUE 2. P. 329-334 22 88% 81
3 TSENG, HC , CACALANO, N , JEWETT, A , (2015) SPLIT ANERGIZED NATURAL KILLER CELLS HALT INFLAMMATION BY INDUCING STEM CELL DIFFERENTIATION, RESISTANCE TO NK CELL CYTOTOXICITY AND PREVENTION OF CYTOKINE AND CHEMOKINE SECRETION.ONCOTARGET. VOL. 6. ISSUE 11. P. 8947 -8959 24 57% 1
4 TSENG, HC , JEWETT, A , MAN, YG , KASAHARA, N , CACALANO, N , BUI, VT , INAGAKI, A , (2015) DIFFERENTIAL TARGETING OF STEM CELLS AND DIFFERENTIATED GLIOBLASTOMAS BY NK CELLS.JOURNAL OF CANCER. VOL. 6. ISSUE 9. P. 866 -876 19 66% 2
5 SIKORA, J , (2009) THE ROLE OF TCR-ZETA EXPRESSION IN IMMUNOSUPPRESSION INDUCED BY TUMOUR.WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY. VOL. 13. ISSUE 5. P. 221-226 25 60% 0
6 WHITESIDE, TL , (2004) DOWN-REGULATION OF ZETA-CHAIN EXPRESSION IN T CELLS: A BIOMARKER OF PROGNOSIS IN CANCER?.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 53. ISSUE 10. P. 865-878 30 48% 94
7 DE BONIFACE, J , POSCHKE, I , MAO, Y , KIESSLING, R , (2012) TUMOR-DEPENDENT DOWN-REGULATION OF THE ZETA-CHAIN IN T-CELLS IS DETECTABLE IN EARLY BREAST CANCER AND CORRELATES WITH IMMUNE CELL FUNCTION.INTERNATIONAL JOURNAL OF CANCER. VOL. 131. ISSUE 1. P. 129-139 23 56% 5
8 KUSS, I , RABINOWICH, H , GOODING, W , EDWARDS, R , WHITESIDE, TL , (2002) EXPRESSION OF ZETA T CELLS PRIOR TO INTERLEUKIN-2 THERAPY AS A PREDICTOR OF RESPONSE AND SURVIVAL IN PATIENTS WITH OVARIAN CARCINOMA.CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. VOL. 17. ISSUE 6. P. 631-640 22 71% 15
9 CHEN, X , WOICIECHOWSKY, A , RAFFEGERST, S , SCHENDEL, D , KOLB, HJ , ROSKROW, M , (2000) IMPAIRED EXPRESSION OF THE CD3-ZETA CHAIN IN PERIPHERAL BLOOD T CELLS OF PATIENTS WITH CHRONIC MYELOID LEUKAEMIA RESULTS IN AN INCREASED SUSCEPTIBILITY TO APOPTOSIS.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 111. ISSUE 3. P. 817 -825 20 77% 20
10 TSENG, HC , BUI, V , MAN, YG , CACALANO, N , JEWETT, A , (2014) INDUCTION OF SPLIT ANERGY CONDITIONS NATURAL KILLER CELLS TO PROMOTE DIFFERENTIATION OF STEM CELLS TNROUGH CELL-CELL CONTACT AND SECRETED FACTORS.FRONTIERS IN IMMUNOLOGY. VOL. 5. ISSUE . P. - 22 48% 2

Classes with closest relation at Level 1


Rank Class id link
1 16097 CD3 GAMMA//CD3 EPSILON//CORE PEPTIDE
2 35146 TNFRSF21//ARA267 ALPHA//BIO THER EUT DISCOVERY
3 7508 TUMOR INFILTRATING LYMPHOCYTES//ADOPTIVE IMMUNOTHERAPY//TIL
4 17426 IRX 2//IMMUNE SUPPRESSOR CELLS//SERV 151Z2
5 7415 MYELOID DERIVED SUPPRESSOR CELLS//MDSC//MYELOID DERIVED SUPPRESSOR CELLS MDSC
6 24733 TUMOR IMMUN TOLERANCE SECT//SV40 T ANTIGEN TRANSGENIC MICE//CCDC134
7 16241 CELLULAR INJURY//TOLERANCE BREAKDOWN//HUNAN MED EPIGEN
8 4080 REGULATORY T CELLS//FOXP3//TUMOR INFILTRATING LYMPHOCYTES
9 8124 TUMOR VACCINE//GENE THERAPY//B71
10 26121 CANCER IMMUNODEFICIENCY//WHOLE BLOOD CELL CULTURES//AZ OSP IST OSPITALIERI VERONA

Go to start page